Biological and molecular studies on specific immune cells treated with checkpoint inhibitors for the thera-personal approach of breast cancer patients (ex-vivo study)

Immunotherapy becomes a promising line of treatment for breast cancer (BC) however, its success rate is still limited. METHODS: The study was designed to optimize the condition for producing an effective dendritic cell (DCs) based immunotherapy by using DCs and T lymphocytes together with tumor-infi...

Descripción completa

Detalles Bibliográficos
Autores principales: EL-HOUSEINI, MOTAWA E., ARAFAT, MOSTAFA S., EL-HUSSEINY, AHMED M., KASEM, ISLAM M., KAMEL, MAHMOUD M., EL-HABASHY, AHMED H., KHAFAGY, MEDHAT M., RADWAN, ENAS M., HELAL, MAHA H., ABDELLATEIF, MONA S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tech Science Press 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207991/
https://www.ncbi.nlm.nih.gov/pubmed/37305162
http://dx.doi.org/10.32604/or.2022.025249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207991/
https://www.ncbi.nlm.nih.gov/pubmed/37305162
http://dx.doi.org/10.32604/or.2022.025249

Ejemplares similares